Personal protective equipment during the coronavirus disease (COVID) 2019 pandemic - a narrative review

T M Cook, T M Cook

Abstract

Personal protective equipment has become an important and emotive subject during the current coronavirus disease 2019 epidemic. Coronavirus disease 2019 is predominantly caused by contact or droplet transmission attributed to relatively large respiratory particles which are subject to gravitational forces and travel only approximately 1 metre from the patient. Airborne transmission may occur if patient respiratory activity or medical procedures generate respiratory aerosols. These aerosols contain particles that may travel much longer distances and remain airborne longer, but their infective potential is uncertain. Contact, droplet and airborne transmission are each relevant during airway manoeuvres in infected patients, particularly during tracheal intubation. Personal protective equipment is an important component, but only one part, of a system protecting staff and other patients from coronavirus disease 2019 cross-infection. Appropriate use significantly reduces risk of viral transmission. Personal protective equipment should logically be matched to the potential mode of viral transmission occurring during patient care - contact, droplet or airborne. Recommendations from international organisations are broadly consistent, but equipment use is not. Only airborne precautions include a fitted high-filtration mask, and this should be reserved for aerosol generating procedures. Uncertainty remains around certain details of personal protective equipment including use of hoods, mask type and the potential for re-use of equipment.

Keywords: COVID-19; airborne; contact; coronavirus; droplet; personal protective equipment.

© 2020 Association of Anaesthetists.

References

    1. Wang W, Xu Y, Gao R, et al. Detection of SARS-CoV-2 in different types of clinical specimens. Journal of the American Medical Association 2020. Epub ahead of print 11 March. .
    1. Public Health England. COVID-19: infection prevention and control guidance. 2020. (accessed 25/03/2020).
    1. van Doremalen N, Bushmaker T, Morris DH, et al. Aerosol and surface stability of HCoV-19 (SARS-CoV-2) compared to SARS-CoV-1. New England Journal of Medicine 2020. Epub ahead of print 13 March. .
    1. Gralton J, Tovey E, McLaws ML, Rawlinson WD. The role of particle size in aerosolised pathogen transmission: a review. Journal of Infection 2011; 62: 1-13.
    1. Nicas M, Nazaroff WW, Hubbard A. Toward understanding the risk of secondary airborne infection: emission of respirable pathogens. Journal of Occupational and Environmental Hygiene 2005; 2: 143-54.
    1. Yu ITS, Li Y, Wong TW, et al. Evidence of Airborne Transmission of the Severe Acute Respiratory Syndrome Virus. New England Journal of Medicine 2004; 350: 1731-9.
    1. Bourouiba L. Turbulent gas clouds and respiratory pathogen emissions: potential implications for reducing transmission of COVID-19. Journal of the American Medical Association 2020. Epub 26 March. .
    1. World Health Organisation. Modes of transmission of virus causing COVID-19: implications for IPC precaution recommendations. 2020. (accessed 31/03/2020).
    1. Surviving Sepsis Campaign: Guidelines on the Management of Critically Ill Adults with Coronavirus Disease 2019 (COVID-19). Intensive Care Medicine doi: 10.1007/s00134-020-06022-5. 2020. (accessed 31/03/2020).
    1. Australasian Society for Infectious Diseases Limited. Interim guidelines for the clinical management of COVID-19 in adults. 2020. (accessed 31/03/2020).
    1. Government of Canada. Coronavirus disease (COVID-19): For health professionals. 2020. (accessed 31/03/2020).
    1. Centers for Disease Control and Prevention. Interim infection prevention and control recommendations for patients with suspected or confirmed coronavirus disease 2019 (COVID-19) in healthcare settings. 2020. (accessed 31/03/2020).
    1. European Centre for Disease Prevention and Control. Infection prevention and control for COVID-19 in healthcare settings. 2020. (accessed 31/03/2020).
    1. Tran K, Cimon K, Severn M, Pessoa-Silva CL, Conly J. Aerosol generating procedures and risk of transmission of acute respiratory infections to healthcare workers: a systematic review. PLoS One 2012; 7: e35797.
    1. Cook TM, El-Boghdadly K, McGuire B, McNarry AF, Patel A, Higgs A. Consensus guidelines for managing the airway in patients with COVID-19. Anaesthesia 2020; 75: 785-99.
    1. Respiratory Therapy Group, Chinese Medical Association Respiratory Branch. Expert consensus on respiratory therapy related to new Coronavirus infection in severe and critical patients. Chinese Journal of Tuberculosis and Respiratory Medicine 2020. Epub ahead of print. 10.3760/cma.j.issn.1001-0939.2020.0020.
    1. Leung CCH, Joynt GM, Gomersall CD, et al. Comparison of high-flow nasal cannula versus oxygen face mask for environmental bacterial contamination in critically ill pneumonia patients: a randomized controlled crossover trial. Hospital Infection 2019; 101: 84-7.
    1. Fowler RA, Guest CB, Lapinsky SE, Sibbald WJ, Louie M, et al. Transmission of severe acute respiratory syndrome during intubation and mechanical ventilation. American Journal of Respiratory and Critical Care Medicine 2004; 169: 1198-202.
    1. Frat JP, Thille AW, Mercat A, et al. High-flow oxygen through nasal cannula in acute hypoxemic respiratory failure. New England Journal of Medicine 2015; 372: 2185-96.
    1. Ni YN, Luo J, Yu H, Liu D, Liang BM, Liang ZA. The effect of high-flow nasal cannula in reducing the mortality and the rate of endotracheal intubation when used before mechanical ventilation compared with conventional oxygen therapy and non-invasive positive pressure ventilation. A systematic review and meta-analysis. American Journal of Emergency Medicine 2018; 36: 226-33.
    1. Ou X, Hua Y, Liu J, Gong C, Zhao W. Effect of high-flow nasal cannula oxygen therapy in adults with acute hypoxemic respiratory failure: a meta-analysis of randomized controlled trials. Canadian Medical Association Journal 2017; 189: E260-7.
    1. Rochwerg B, Granton D, Wang DX, et al. High flow nasal cannula compared with conventional oxygen therapy for acute hypoxemic respiratory failure: a systematic review and meta-analysis. Intensive Care Medicine 2019; 45: 563-72.
    1. Alhazzani W, Hylander Møller M, Arabi YM, et al. Surviving Sepsis Campaign: guidelines on the management of critically ill adults with coronavirus disease 2019 (COVID-19). Intensive Care Medicine 2020. Epub ahead of print 28 March. .
    1. Leung NHL, Chu DKW, Shiu EYC, et al. Respiratory virus shedding in exhaled breath and efficacy of face masks. Nature Medicine 2020. Epub 3 April. (accessed 08/04/2020).
    1. BS EN 149:2001+A1:2009 Respiratory Protective Devices. Filtering half masks to protect against particles. Requirements, testing, marking. British Standard Institute. 2009. (accessed 28/03/2020).
    1. Gawn J, Clayton M, Makison C, Crook B Evaluating the protection afforded by surgical masks against influenza bioaerosols Gross protection of surgical masks compared to filtering facepiece respirators Prepared by the Health and Safety Laboratory for the Health and Safety Executive HSE Books. 2008. (accessed 26/03/2020).
    1. NIOSH Guide to the Selection and Use of Particulate Respirators. Centres for disease control and prevention. DHHS (NIOSH) Publication Number 96-101. 1996. (accessed 26/03/2020).
    1. World Health organisation. Rational use of personal protective equipment (PPE) for coronavirus disease (COVID-19). 2020. (accessed 26/03/2020).
    1. Radonovich LJ Jr, Cheng J, Shenal BV, Hodgson M, Bender BS. Respirator tolerance in health care workers. Journal of the American Medical Association 2009; 301: 36-8.
    1. Coia J, Ritchie L, Adisesh A, et al. Guidance on the use of respiratory and facial protection equipment. Journal of Hospital Infection 2013; 85: 170-82.
    1. Department of Health. Health Technical Memorandum 03-01: specialised ventilation for healthcare premises. Part A - design and installation. Estates and Facilities Division. London: The Stationery Office, 2007.
    1. World Health Organization. Clinical management of severe acute respiratory infection when novel coronavirus (nCoV) infection is suspected. 2020. (accessed 26/03/2020).
    1. Public Health England. When to use a surgical face mask or FFP3 respirator. 2020. (accessed 26/03/2020).
    1. Nicolle L. SARS safety and science. Canadian Journal of Anesthesia 2003; 50: 983-8.
    1. NHS England and NHS Improvement. FAQs on using FFP 3 Respiratory Protective Equipment (RPE). 2020. (accessed 26/03/2020).
    1. Verbeek JH, Rajamaki B, Ijaz S, et al. Personal protective equipment for preventing highly infectious diseases due to exposure to contaminated body fluids in healthcare staff. Cochrane Database of Systematic Reviews 2019; 7: CD011621.
    1. Zamora JE, Murdoch J, Simchison B, Day AG. Contamination: a comparison of 2 personal protective systems. Canadian Medical Association Journal 2006; 175: 249-54.
    1. Offeddu V, Yung CF, Low MSF, Tam CC. Effectiveness of masks and respirators against respiratory infections in healthcare workers: a systematic review and meta-analysis. Clinical Infectious Diseases 2017; 65: 1934-42.
    1. Meng L, Qiu H, Wan L, et al. Intubation and ventilation amid the COVID-19 outbreak: Wuhan's experience. Anesthesiology 2020. Epub ahead of print 19 March. .
    1. Yao W, Wang T, Jiang B, et al. Emergency tracheal Intubation in 202 patients with COVID-19 in Wuhan, China: lessons learnet and expert recommendations. British Journal of Anaesthesia 2020. Epub 10 April. .
    1. Chu S, Liao L, Xiao W, et al. Can N95 facial masks be used after disinfection? And for how many times? Report from the collaboration of Stanford University and 4C Air, Inc. 2020. (accessed 31/03/2020).
    1. Casanova LM, Rutala WA, Weber DJ, Sobsey MD. Effect of single- versus double gloving on virus transfer to health care workers’ skin and clothing during removal of personal protective equipment. American Journal of Infection Control 2012; 40: 369-74.

Source: PubMed

Спонсоры и соавторы

Заболевания

Медикаментозные вмешательства

Подписаться